Table 1.
Studies demonstrating evidence of cognitive impairments induced by regular khat use or synthetic cathinones in human subjects.
| Drug | Use patterns | Cognitive deficits | Reference |
|---|---|---|---|
| khat | daily, almost daily or occasional use | ↓ visuoperceptual memory and fluency, spatial memory, short and long-term memory | (Khattab and Amer 1995) |
| ≥1 yr regular use | ↓ response inhibition | (Colzato et al. 2010) | |
| ≥1 yr regular use | ↓ cognitive flexibility, working memory | (Colzato et al. 2011) | |
| ≥1 yr daily use | ↓ working memory, n.c. information processing speed | (Hoffman and al’Absi 2013b) | |
| ≥1x week, >1 yr | ↓ serial learning, psychomotor speed, set-shifting | (Ismail et al. 2014) | |
| mephedrone | >1 yr of regular use | ↓ verbal recall and fluency | (Freeman et al. 2012) |
| <48 hr prior to psychological test | ↓ verbal recall and fluency | (Herzig et al. 2013) | |
| ≥1x month; self-reported use examined over 9 d | ↑ self-reported cognitive impairment (unspecified) | (Homman et al. 2018) | |
| ≥6x prior use;; acute 200 mg dose administered p.o. | ↓ short term memory, n.c. divided attention effects not counteracted by alcohol (0.8 g/kg) | (de Sousa Fernandes Perna et al. 2016) |